1. 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. (1st January 2022) Authors: Elbadawi, Mostafa M.; Eldehna, Wagdy M.; Abd El-Hafeez, Amer Ali; Somaa, Warda R.; Albohy, Amgad; Al-Rashood, Sara T.; Agama, Keli K.; Elkaeed, Eslam B.; Ghosh, Pradipta; Pommier, Yves; Abe, Manabu Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 37:Number 1(2022) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. (31st December 2022) Authors: Elbadawi, Mostafa M.; Eldehna, Wagdy M.; Abd El-Hafeez, Amer Ali; Somaa, Warda R.; Albohy, Amgad; Al-Rashood, Sara T.; Agama, Keli K.; Elkaeed, Eslam B.; Ghosh, Pradipta; Pommier, Yves; Abe, Manabu Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 37:Number 1(2022) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A polymer index-matched to water enables diverse applications in fluorescence microscopy. Issue 8 (25th February 2021) Authors: Han, Xiaofei; Su, Yijun; White, Hamilton; O'Neill, Kate M.; Morgan, Nicole Y.; Christensen, Ryan; Potarazu, Deepika; Vishwasrao, Harshad D.; Xu, Stephen; Sun, Yilun; Huang, Shar-yin; Moyle, Mark W.; Dai, Qionghai; Pommier, Yves; Giniger, Edward; Albrecht, Dirk R.; Probst, Roland; Shroff, Hari Journal: Lab on a chip Issue: Volume 21:Issue 8(2021) Page Start: 1549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alkyne Activation in the Diversity Oriented Synthesis of sp2‐Rich Scaffolds: A Biased Library Approach for Targeting Polynucleotides (DNA/RNA). Issue 71 (3rd November 2022) Authors: Chen, Shuqi; Priebbenow, Daniel L.; Somkhit, Julie; Scullino, Carmen V.; Agama, Keli; Pommier, Yves; Flynn, Bernard L. Journal: Chemistry Issue: Volume 28:Issue 71(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Authentic HIV-1 integrase inhibitors. (July 2010) Authors: Liao, Chenzhong; Marchand, Christophe; Burke Jr, Terrence R; Pommier, Yves; Nicklaus, Marc C Journal: Future medicinal chemistry Issue: Volume 2:Number 7(2010) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Beyond the unwinding: role of TOP1MT in mitochondrial translation. Issue 19 (2nd October 2019) Authors: Baechler, Simone A; Dalla Rosa, Ilaria; Spinazzola, Antonella; Pommier, Yves Journal: Cell cycle Issue: Volume 18:Issue 19(2019) Page Start: 2377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics. Issue Volume 49:Issue D1(2021) (16th November 2020) Authors: Luna, Augustin; Elloumi, Fathi; Varma, Sudhir; Wang, Yanghsin; Rajapakse, Vinodh N; Aladjem, Mirit I; Robert, Jacques; Sander, Chris; Pommier, Yves; Reinhold, William C Journal: Nucleic acids research Issue: Volume 49:Issue D1(2021) Page Start: D1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. Issue 1 (December 2016) Authors: Jensen, Niels; Agama, Keli; Roy, Amit; Smith, David; Pfister, Thomas; Rømer, Maria; Zhang, Hong-Liang; Doroshow, James; Knudsen, Birgitta; Stenvang, Jan; Brünner, Nils; Pommier, Yves Journal: Journal of experimental & clinical cancer research Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTNI-58. IMPROVING TRIAL ACCESS FOR PEOPLE WITH RARE CNS TUMORS: AN NCI-CONNECT PHASE I/II TRIAL OF PLX038 IN TUMORS WITH MYC/MYCN AMPLIFICATIONS INCORPORATING CORRELATIVE STUDIES AND PATIENT REPORTED OUTCOMES. (14th November 2022) Authors: Penas-Prado, Marta; Wooley, Joseph; Jung, Jinkyu; Yuan, Ying; Zhang, Meili; Baranello, Laura; Briceno, Nicole; Levens, David; Mendoza, Tito; Pommier, Yves; Thomas, Craig; Vera, Elizabeth; Santi, Daniel; Armstrong, Terri; Gilbert, Mark Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov–Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins. (1st June 2021) Authors: Rasapalli, Sivappa; Sammeta, Vamshikrishna Reddy; Murphy, Zachary F.; Golen, James A.; Agama, Keli; Pommier, Yves; Savinov, Sergey N. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 41(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗